Astrana Health (NASDAQ:ASTH) Reaches New 52-Week High at $46.10

Shares of Astrana Health, Inc. (NASDAQ:ASTH) reached a new 52-week high during trading on Friday . The stock traded as high as $46.10 and last traded at $46.09, with a volume of 21247 shares traded. The stock had previously closed at $45.00.

Wall Street Analysts Forecast Growth

ASTH has been the topic of several research analyst reports. Truist Financial raised shares of Astrana Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $44.00 to $50.00 in a report on Thursday. Robert W. Baird initiated coverage on shares of Astrana Health in a research note on Thursday, May 30th. They set an “outperform” rating and a $54.00 price target on the stock. Baird R W raised shares of Astrana Health to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Stifel Nicolaus upped their price target on shares of Astrana Health from $45.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, June 27th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Astrana Health presently has an average rating of “Buy” and a consensus price target of $50.50.

Astrana Health Price Performance

The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.56. The stock has a market cap of $2.57 billion, a price-to-earnings ratio of 34.09, a P/E/G ratio of 1.36 and a beta of 1.16. The stock’s 50-day simple moving average is $40.00.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). The company had revenue of $404.36 million during the quarter, compared to analysts’ expectations of $413.84 million. Astrana Health had a return on equity of 10.22% and a net margin of 4.29%. The company’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.42 EPS. As a group, sell-side analysts expect that Astrana Health, Inc. will post 1.41 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.